financetom
Business
financetom
/
Business
/
Honda, Nissan set to announce launch of integration talks, media reports say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honda, Nissan set to announce launch of integration talks, media reports say
Dec 22, 2024 4:14 PM

TOKYO, Dec 23 (Reuters) - Honda ( HMC ) and Nissan ( NSANF )

are expected on Monday to announce the start of

business integration talks, according to Japanese media reports,

as the automakers look to survive a rapidly changing industry

landscape.

The two automakers will likely host board meetings on Monday

about the talks and later hold a joint press conference, where

Nissan's ( NSANF ) alliance partner Mitsubishi Motors ( MMTOF ) is also

expected to attend, the reports said.

A merger of the three Japanese brands would create the

world's No. 3 auto group by vehicle sales after Toyota ( TM )

and Volkswagen, in what would be the biggest

industry-reshaping deal since the 2021 formation of Stellantis ( STLA )

.

Honda ( HMC ) and Nissan ( NSANF ) have been exploring ways to bolster their

partnership, including setting up a joint holding company, as

they face growing challenges from Tesla and Chinese

rivals, Reuters reported last week. Nissan ( NSANF ) last month announced

a plan to cut 9,000 jobs and 20% of its global production

capacity after its sales plunged in its key China and U.S.

markets.

Forms of collaboration being discussed also include Honda's ( HMC )

supply of hybrid vehicles to Nissan ( NSANF ) and the joint use of

Nissan's ( NSANF ) car assembly factory in Britain, Kyodo News reported on

Saturday.

French automaker Renault, Nissan's ( NSANF ) largest

shareholder, is open in principle to a deal and would examine

all the implications of a tie-up, sources have said.

Taiwanese manufacturer Foxconn had approached

Nissan ( NSANF ) about a potential bid but paused its interest after it

sent a delegation to meet with Renault in France, Bloomberg News

reported on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Niu Technologies Posts Higher Sales Volume in Q4, 2024
Niu Technologies Posts Higher Sales Volume in Q4, 2024
Jan 6, 2025
04:31 AM EST, 01/06/2025 (MT Newswires) -- Niu Technologies ( NIU ) said Monday it has sold 226,634 units in Q4, up from 137,476 units a year earlier. For full-year 2024, the Chinese producer of electric-powered motorcycles, mopeds, bicycles and scooters said it sold 924,340 units, up from 709,802 units a year earlier. ...
Tenable Holdings CEO Amit Yoran Passes Away
Tenable Holdings CEO Amit Yoran Passes Away
Jan 6, 2025
04:35 AM EST, 01/06/2025 (MT Newswires) -- Tenable Holdings ( TENB ) said Saturday that Chairman and CEO Amit Yoran has passed away after a battle with cancer. The company said Yoran took a medical leave starting Dec. 5, 2024, and the board appointed CFO Steve Vintz and COO Mark Thurmond as co-CEOs to maintain leadership and stability. The board...
BRIEF-Smart Share Global Gets Prelim Takeover Proposal For $0.625/Share or $1.25/ADS
BRIEF-Smart Share Global Gets Prelim Takeover Proposal For $0.625/Share or $1.25/ADS
Jan 6, 2025
Jan 6 (Reuters) - Smart Share Global Ltd ( EM ): * SMART SHARE GLOBAL LIMITED ANNOUNCES RECEIPT OF A PRELIMINARY NON-BINDING PROPOSAL TO ACQUIRE THE COMPANY * PROPOSAL TO ACQUIRE SHARES AT $0.625 PER ORDINARY SHARE OR $1.25 PER ADS * PROPOSAL FROM TRUSTAR MOBILE CHARGING, CO'S CEO, CFO, PRESIDENT & OTHERS Source text: Further company coverage: ...
Oculis Holding Says Phase 2 Trial of Acute Optic Neuritis Therapy Met Primary Safety Endpoint
Oculis Holding Says Phase 2 Trial of Acute Optic Neuritis Therapy Met Primary Safety Endpoint
Jan 6, 2025
05:01 AM EST, 01/06/2025 (MT Newswires) -- Oculis Holding ( OCS ) said Monday a phase 2 trial evaluating OCS-05 in patients with acute optic neuritis met the primary endpoint of safety and achieved statistical significance on several efficacy-based secondary endpoints. Acute optic neuritis is a condition characterized by inflammation of the optic nerve that can results in permanent visual...
Copyright 2023-2026 - www.financetom.com All Rights Reserved